Evidence map›Paper›PMID 42194254›Full record

ArticleBioengineering (Basel, Switzerland)2026

Prediction Pipeline Selection for Incomplete Clinical Data via Missingness Fingerprints and Instance Augmentation.

Runze Li, Zhuyi Shen, Chengkai Wu, Jingsong Li, Yu Tian

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Runze LiCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou 310027, China.ORCID 0009-0004-9380-3407
Zhuyi ShenSchool of Intelligent Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.ORCID 0000-0002-6333-3633
Chengkai WuSchool of Intelligent Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.ORCID 0000-0002-8064-4070
Jingsong LiCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou 310027, China.ORCID 0000-0002-1064-637X
Yu TianCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou 310027, China.ORCID 0000-0002-6791-8217

Funding

Fundamental Research Funds for the Central Universities 226-2025-00006National Natural Science Foundation of China 62402455National Natural Science Foundation of China 82172069National Natural Science Foundation of China 82572379
6 · The paper itself

Abstract

Clinical prediction from electronic health records (EHRs) is complicated by pervasive missingness and label scarcity, which make performance sensitive to the match between data conditions and pipeline choice. Choosing the best pipeline for a new incomplete dataset still requires costly trial-and-error. We cast this as an algorithm selection problem and address two bottlenecks-instance scarcity and distance quality-that have so far prevented meta-learning from reaching clinical settings. Graph neural networks offer diverse strategies (patient similarity networks, bipartite imputation graphs, attention-driven feature interaction), yet no single architecture dominates across missingness patterns, and selecting the best pipeline for a new dataset remains a trial-and-error approach. Formal algorithm selection could automate this choice but requires many characterized meta-instances-more than clinical settings typically provide. We propose two solutions: (1) constructive instance augmentation, applying controlled quality perturbations (MCAR and MNAR missingness injection, label trimming) to 20 base EHR datasets to expand the meta-knowledge base to 83 characterized meta-instances, each described by a 10-dimensional missingness fingerprint, without additional model training; and (2) dynamic-supervised metric learning, using differential evolution to optimize fingerprint feature weights so that static distances preserve method-performance similarity captured by dynamic fingerprints, which require model sweeps and are unavailable at deployment. Under base-dataset-level leave-one-dataset-out cross-validation over 21 pipelines, the resulting metric-learned kNN recommender attains the highest win rate (20.5%) among non-oracle strategies on the augmented store, selecting the correct pipeline more often than any fixed default. At deployment, the recommender needs only the 10-dimensional static fingerprint with pre-learned weights; no sweep data is required for new datasets. Cross-domain evaluation on 25 external subsets (colorectal cancer, kidney disease, MIMIC-IV) demonstrates framework modularity: when the fingerprint module is adapted (standard meta-features in place of the missingness-specific set), the recommender achieves regret of 0.025 (55% below random selection).

Indexed as

algorithm selectionclinical predictionelectronic health recordsgraph neural networksinstance space analysismeta-learningmissing data

Identifiers

PMID42194254
PMCPMC13203696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.